Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Heron Therapeautics Inc | HRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.55 | 04:00:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.55 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.50 - 3.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.55 | USD |
Heron Therapeautics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 383.34M | 150.33M | - | 127.04M | -110.56M | -0.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Heron Therapeautics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 3.145 | 2.46 | 2.69 | 3,052,604 | -0.16 | -5.90% |
| 1 Month | 2.80 | 3.145 | 2.46 | 2.74 | 1,845,737 | -0.25 | -8.93% |
| 3 Months | 2.40 | 3.22 | 2.16 | 2.75 | 2,232,993 | 0.15 | 6.25% |
| 6 Months | 0.70 | 3.22 | 0.50 | 2.01 | 2,968,350 | 1.85 | 264.29% |
| 1 Year | 2.48 | 3.22 | 0.50 | 1.73 | 2,531,680 | 0.07 | 2.82% |
| 3 Years | 17.30 | 18.99 | 0.50 | 4.58 | 2,352,680 | -14.75 | -85.26% |
| 5 Years | 23.84 | 26.858 | 0.50 | 7.73 | 1,837,125 | -21.29 | -89.30% |
Heron Therapeautics Description
| Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. |
